References
- Goldner W. Cancer-Related hypercalcemia. J Oncol Pract. 2016;12(5):426–432.
- Oyajobi BO. Multiple myeloma/hypercalcemia. Arthritis Res Ther. 2007;9 Suppl 1:S4.
- Panaroni C, Yee AJ, Raje NS. Myeloma and bone disease. Curr Osteoporos Rep. 2017;15(5):483–498.
- Hu MI, Glezerman IG, Leboulleux S, et al. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014;99(9):3144–3152.
- Raje N, Terpos E, Willenbacher W, et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. The Lancet. Oncology. 2018;19(3):370–381.
- Block GA, Bone HG, Fang L, et al. A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res. 2012;27(7):1471–1479.
- Dave V, Chiang CY, Booth J, et al. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4–5. Am J Nephrol. 2015;41(2):129–137.
- Group AKIW. Kidney disease: Improving global outcomes (KDIGO) - Clinical practice guideline for acute kidney injury. Kidney Inter. 2012;2:1–138.
- Kastritis E, Terpos E, Roussou M, et al. Evaluation of the revised international staging system in an independent cohort of unselected patients with multiple myeloma. Haematologica. 2017;102(3):593–599.
- Morgan KP, Sun Y, Deal A, et al. Denosumab for First-Line treatment of hypercalcemia associated with malignancy: Retrospective analysis. Journal of Hematology Oncology Pharmacy. 2021;11:121–126.
- Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19(2):558–567.
- Nasser SM, Sahal A, Hamad A, et al. Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: a retrospective cohort study. J Oncol Pharm Pract. 2019;25(8):1846–1852.
- Menshawy A, Mattar O, Abdulkarim A, et al. Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and Meta-analysis of randomized controlled trials. Support Care Cancer. 2018;26(4):1029–1038.
- Lexicomp Online. Waltham, MA 2022. https://online.lexi.com